Gene transfer into human leukemia cell lines by electroporation: experience with exponentially decaying and square wave pulse. 1991

M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
First Department of Internal Medicine, Niigata University, School of Medicine, Japan.

The efficiency of gene transfer into human leukemia cell lines by electroporation was investigated. For both transient expression (beta-galactosidase gene) and stable transformation (neomycin resistance gene), the transfer efficiency into leukemia cell lines using a square wave pulse was superior to that using an exponentially decaying wave. The transfer rate of pMoZtk (containing beta-galactosidase gene) into K562 by electroporation using a square wave was approximately 5%, compared with 1% by an exponentially decaying pulse. Whereas the transfer rate of pMAM-neo into K562 by electroporation using an exponentially decaying pulse was less than 10(-5), a square wave generated much more efficient introduction rate of nearly 10(-3). In the other leukemia cell lines also, some square wave yields were better than exponential yields and all square wave yields were at least as good as the exponential yields.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D009355 Neomycin Aminoglycoside antibiotic complex produced by Streptomyces fradiae. It is composed of neomycins A, B, and C, and acts by inhibiting translation during protein synthesis. Fradiomycin Sulfate,Neomycin Palmitate,Neomycin Sulfate
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D004560 Electricity The physical effects involving the presence of electric charges at rest and in motion.
D005818 Genetic Engineering Directed modification of the gene complement of a living organism by such techniques as altering the DNA, substituting genetic material by means of a virus, transplanting whole nuclei, transplanting cell hybrids, etc. Genetic Intervention,Engineering, Genetic,Intervention, Genetic,Genetic Interventions,Interventions, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
May 1990, Plant cell reports,
M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
August 1998, BioTechniques,
M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
May 1987, Physical review. A, General physics,
M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
November 1988, Physical review. A, General physics,
M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
September 1989, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
January 1998, International journal of hematology,
M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
January 1995, Methods in molecular biology (Clifton, N.J.),
M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
January 1987, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
September 1998, Nature biotechnology,
M Takahashi, and T Furukawa, and H Saitoh, and A Aoki, and T Koike, and Y Moriyama, and A Shibata
January 2002, Methods in molecular medicine,
Copied contents to your clipboard!